Dr. Yi Chen
Recent Articles about First Wave BioPharma Inc.
777% Gain Implied in Analyst's Target Price on Biopharma Co. 06/14/2023
Results from a Phase 2 trial of this U.S. company's cystic fibrosis drug are due out next month, noted an H.C. Wainwright & Co. report.
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
